TAMARA MADJID: Open Payments
NPI 1497908032 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 66 payments from 15 companies in 2025. Trend: 2023 $777 · 2024 $875 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 38 | $273 |
| MILLICENT US INC | 6 | $116 |
| ABBVIE INC. | 1 | $89 |
| Astellas Pharma US Inc | 3 | $78 |
| Hologic Sales and Service, LLC | 2 | $74 |
| Sage Therapeutics, LLC | 3 | $55 |
| Organon LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| PFIZER INC. | 2 | $38 |
| SHIELD THERAPEUTICS INC | 1 | $36 |
Products named: QULIPTA, FEMLYV, Veozah, ZURZUVAE, FLUENT FLUID MANAGEMENT SYSTEM, NEXPLANON, ABRYSVO, ACCRUFER.
Industry payments across OK — which companies pay providers there.
